The OMICS and PD models: Hopes or hypes

Omics technologies have the potential to significantly improve the diagnosis, treatment, and prevention of Parkinson's disease. Currently, the diagnosis of Parkinson's disease is mostly dependent on clinical symptoms, which can be difficult because symptoms might overlap with other neurodegenerative conditions. Omics technologies, on the other hand, offer the ability to find distinct molecular signals that might help in the early and accurate diagnosis of Parkinson's disease. Biomarkers discovered using omics technologies, such as alpha-synuclein and different metabolites, might also be utilized to construct disease diagnostic tests. Furthermore, by discovering possible therapeutic targets, omics technologies can contribute to the discovery of novel therapeutics for Parkinson's disease. Researchers can uncover critical biochemical pathways that are changed in Parkinson's disease and may be responsive to therapeutic intervention by combining data from diverse omics methods. Targeting dysregulated pathways discovered by omics technologies, such as inflammation, oxidative stress, and protein misfolding, might lead to the creation of novel medications that reduce or stop disease progression. Omics technology can potentially help with Parkinson's disease prevention. It can contribute to the development of preventative therapies by recognizing molecular alterations that occur in the early stages of illness example, which might lead to the development of therapies that prevent or postpone the onset of the illness.